Use the fast links below to go to a board member's biography.
Sandra Anderson BSc PhD DSc FANZSRS
Dr Sandra Anderson is an expert in the diagnosis and treatment of asthma. She is a world authority in the measurement, management and mechanisms of exercise-induced asthma, and has developed a variety of tests for identifying asthma, including Aridol.
A prolific author and the recipient of numerous awards for her work, Sandra is Principal Hospital Scientist in the Department of Respiratory Medicine of the Royal Prince Alfred Hospital, Sydney. She is a Vice President of Asthma NSW and is the Co-Chairman of their Research Advisory Committee. Sandra has served on various international task forces and committees and is currently part of an independent panel of the International Olympic Committee Medical Commission.
Sandra is actively engaged in the company's development, participating in technical presentations to various opinion leaders and regulatory authorities around the world.
Norbert Berend AM MBBS MD FRACP
Dr Norbert Berend is Director of the Woolcock Institute of Medical Research at Royal Prince Alfred Hospital, Sydney and is internationally recognised for his work in chronic obstructive pulmonary disease (COPD).
Norbert is active in national and international peer groups, is a member of the COPD Guidelines Working Party, and serves on the Respiratory Clinical Expert Reference Committee of the NSW Department of Health. In addition, Norbert is a Senior Investigator for the Cooperative Research Centre (CRC) for asthma and a Director of the CRC for Chronic Inflammatory Diseases. He is author of more than 95 publications on airways disease, emphysema and infection in COPD.
Norbert was a principal investigator at one site participating in the Aridol trial as well as serving on trial related safety committees.
Professor Malcolm Fisher is renowned for his work in critical care medicine, having received numerous awards and being named an officer in the Order of Australia.
Based in Sydney, Malcolm is a Staff Specialist in the Intensive Care Unit of Royal North Shore Hospital, and Area Director of Intensive Care and Clinical Professor in Intensive Care Medicine, Departments of Medicine and Anaesthesia, University of Sydney. He is a past President of the World Federation of Intensive and Critical Care Medicine Societies, and its Australian chapter, ANZICS. He is the author of two books and more than 130 scientific articles.
Richard JI Morgan CBiol MIBiol DRCPath
Richard has more than 25 years' experience in pharmaceutical research and development, and has been involved in the development of a large number of successful, marketed pharmaceutical products.
He has held senior management positions within preclinical safety (a vital precursor to human trials), including Head of Toxicology at pharmaceutical giant Wellcome plc and International Head of Toxicology and Preclinical Outsourcing for GlaxoWellcome (later GlaxoSmithKline). He has been responsible for evaluating the preclinical safety of more than 100 new chemical entities, ranging from anti-infectives and anti-parasitics to cancer compounds and vaccines. Richard currently advises UK and Australian companies on toxicology and preclinical discovery and development.
Richard consults to the company on the preclinical safety aspects of developing products.
Top
